Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Why Merck Is Sending Seagen Stock Higher Today
09:25am, Thursday, 07'th Jul 2022
Seagen Inc (NASDAQ: SGEN) shares are trading higher Thursday following reports suggesting Merck & Company Inc (NYSE: MRK) is in advanced talks to acquire the company. According to a Wall Street Jou
Merck's Potential Buyout Of Seagen Expected Within Next Few Weeks: Report
07:35am, Thursday, 07'th Jul 2022
Merck & Co Inc (NYSE: MRK) is in advanced talks to acquire Seagen Inc (NASDAQ: SGEN), and an agreement on a purchase is expected in the next few weeks, Wall Street Journal reported citing people
Merck in talks to buy cancer biotech Seagen: report
12:30am, Thursday, 07'th Jul 2022
Merck & Co is reportedly in talks to acquire biotech company Seagen Inc. in a nearly $40 billon deal that would add to the company's cancer drug portfolio.
Merck in advanced talks to buy Seagen in $40-billion deal - WSJ
10:51pm, Wednesday, 06'th Jul 2022
Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported on Wednesday.
Trial Results Set to Make or Break Small-Cap Pharma Stocks
04:15pm, Wednesday, 06'th Jul 2022
One analyst is putting the odds at three to one that tests of a Karuna Therapeutics Inc. ( KRTX , Financial) schizophrenia drug will meet study objectives, paving the way to Food and Drug Administrati
Top 5 Nasdaq Stocks Flying High Amid Index's Bloodbath in 1H
10:06am, Tuesday, 05'th Jul 2022
We have narrowed our search to five Nasdaq Composite listed stocks that have witnessed a double-digit rally year to date. These are: AEP, AZPN, SGEN, DLTR and TMUS.
Oncology ABCs: A Small-Cap Biopharma Prospectus Series
09:30am, Monday, 04'th Jul 2022
Oncology remains the fastest growing pharma segment, where innovation is largely driven by emerging small companies. The global oncology market is estimated at c US$175–180bn and is anticipated to m
A Buyout-Driven Pair Trade: Buy Aurinia, Sell Merck (Or Seagen If You Must)
09:22am, Monday, 04'th Jul 2022
The most recent two hottest potatoes in the biotech arena are Aurinia Pharmaceuticals and Seagen. While the latter is mostly/recently associated with an upcoming Merck buyout, the former has been asso
Here's Why Seattle Genetics (SGEN) is a Great Momentum Stock to Buy
02:52pm, Thursday, 30'th Jun 2022
Does Seattle Genetics (SGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Seagen (SGEN) Up More Than 20% in Past 3 Months: Here's Why
01:55pm, Wednesday, 29'th Jun 2022
Seagen (SGEN) is riding on the strong uptake of its marketed drugs that are approved for different cancer indications. Further label expansion of these drugs should boost the top line.
Investors Need Not Be Alarmed by Drug Patent Expirations
04:02pm, Tuesday, 28'th Jun 2022
Investors who are sweating the loss of patent protection for some of Big Pharma's top-selling drugs should relax.
Seagen Would Be A Great Fit For Merck
09:57am, Sunday, 26'th Jun 2022
Seagen had two setbacks this year - the below-consensus FY2022 guidance and the resignation of CEO Siegall. The stock shot up this month when rumors surfaced that Merck is interested in acquiring the
Should You Sell Biotech Stocks If There's a Recession?
10:37am, Thursday, 23'rd Jun 2022
It's probably better to think about whether to buy more shares.
Seagen (SGEN) Stock Up on Rumors of Acquisition by Merck
01:59pm, Monday, 20'th Jun 2022
Shares of Seagen (SGEN) rise after rumors of a buyout by Merck hit the market. However, a deal is not imminent at the moment.
Seattle Genetics (SGEN) Moves 12.7% Higher: Will This Strength Last?
10:06am, Monday, 20'th Jun 2022
Seattle Genetics (SGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more st
